SimthKlineBeecham news from FierceHealthcare
News
More objections to Avandia suppressed by Glaxo
We haven't heard anything for a while about Avandia, GlaxoSmithKline's diabetes drug that has been linked to a higher risk of heart attacks, but that doesn't mean no one has been paying attention.... Read more...





